Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - atenolol - oral tablet - 100mg

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

berk pharmaceuticals limited - methyldopa - tablets - 125 milligram

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

berk pharmaceuticals limited - methyldopa - tablets - 250 milligram

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

berk pharmaceuticals limited - methyldopa - tablets - 500 milligram

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

camox pharmaceuticals (pty) ltd - tablet - each tablet contains methyldopa 250 mg

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

alliance pharma (pty) ltd - tablet - see ingredients - each tablet contains methyldopa 500 mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - atenolol - oral tablet - 50mg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - atenolol - oral tablet - 25mg

ABD - İngilizce - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - major depressive disorder: paroxetine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets, usp in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology—clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets, usp in hospitalized depressed patients have not been adequa

Panama - İngilizce - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

unipharm international, s.a. - amlodipina (besilato) - amlodipina (besilato)....5 mg